Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT

This study has been terminated.

(Difficulties in recruiting patients)

Sponsor:

Information provided by (Responsible Party):

Won Ki Kang, Samsung Medical Center

ClinicalTrials.gov Identifier:

NCT01106066

First received: April 15, 2010

Last updated: June 12, 2013

Last verified: June 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	November 2012
Primary Completion Date:	November 2012 (Final data collection date for primary outcome measure)